Conventionally, the detection of CTC linked to PDA is based on the methodologies including density centrifugation and RT-PCR detection of tumor markers CEA [38], cytokeratin 20 [39], or EpCAM [40]. This evidence concerns the gene EPCAM and Patent ductus arteriosus.